An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
Completed · Phase 4
Conditions studied: Seborrheic Keratosis
In brief
This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Key facts
- Study ID
- NCT03487588
- Run by
- Aclaris Therapeutics, Inc.
- People needed
- 41
- Starts
- 2018-03-21
- Expected to finish
- 2018-11-14
- Last updated by the study team
- 2019-10-02
Who can join
Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject can comprehend and is willing to sign an informed consent for participation in this study.
- Male or female between the ages of 30 and 75 years old.
- Subject has 3 eligible Seborrheic Keratoses; 2 target SKs must be on the face, and the additional 1 target SK must be on the neck or decolletage.
- Subjects must have had cryosurgery for SK removal within the last 6 months and prior to first treatment with A-101 Topical Solution.
- Target and non-target SKs must not have been previously treated.
- Subject is in good general health and free of any known disease state or physical condition which, in the investigator's opinion, might impair the evaluation of any target or non-target SK or which exposes the subject to an unacceptable risk by study participation
You may not qualify if…
- Subject has clinically atypical and /or rapidly growing Seborrheic Keratoses.
- Subject has current systemic malignancy.
- Subject would require the use of any topical treatment (e.g., moisturizers, sunscreens) to any of the target or non-target SKs 12 hours prior to any study visit.
- Subject has any current skin disease (e.g., psoriasis, atopic dermatitis, eczema, sun damage), or condition (e.g., sunburn, excessive hair, open wounds) that, in the opinion of the investigator, might put the subject at undue risk by study participation or interfere with the study conduct or evaluations
Where it is running
- Aclaris Investigational Site — Fort Washington, Pennsylvania, United States
- Aclaris Investigational Site — Knoxville, Tennessee, United States
- Aclaris Investigational Site — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.